Related Experiment Video
Updated: Jun 9, 2026
11:05
Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Published on: January 7, 2019
9.5K
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Clara Bueno1,2,3, Raul Torres-Ruiz1,4,5,6,7, Talia Velasco-Hernandez1,2
1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Blood
|September 27, 2023
Summary
Cellular development and MLL gene alterations are key to how MLL-edited cells cause infant B-cell acute lymphoblastic leukemia (B-ALL). This study reveals critical factors driving MLL-AF4+ infant B-ALL.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Infant B-cell acute lymphoblastic leukemia (B-ALL) is a complex disease with distinct genetic drivers.
- The mixed lineage leukemia (MLL) gene rearrangements are frequently observed in infant B-ALL, leading to specific oncogenic pathways.
Discussion:
- Cellular ontogeny, referring to the developmental stage of cells, plays a crucial role in leukemogenesis.
- The specific breakpoint site within the MLL gene significantly impacts the leukemic potential of edited hematopoietic stem cells.
Key Insights:
- MLL-edited CD34+ hematopoietic cells' capacity to initiate leukemia is influenced by their developmental stage and the MLL breakpoint.
- Specific MLL-AF4 rearrangements are identified as critical determinants in the development of infant B-ALL.
- Understanding these factors provides a foundation for targeted therapeutic strategies.
Outlook:
- Further research into the precise mechanisms by which MLL rearrangements drive leukemogenesis is warranted.
- Investigating the role of cellular ontogeny in MLL-driven leukemias may reveal novel therapeutic targets.
- Developing strategies to target MLL-AF4+ B-ALL based on these insights could improve patient outcomes.
